These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4696262)

  • 21. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 22. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in medium-size plants].
    Schmid HW
    Pharm Acta Helv; 1973; 48(6):339-57. PubMed ID: 4729556
    [No Abstract]   [Full Text] [Related]  

  • 23. Facilitating aseptic mixing of sterile substances.
    Ing TS; Daugirdas JT; Purandare VV
    Am J Hosp Pharm; 1985 Jul; 42(7):1511. PubMed ID: 4025346
    [No Abstract]   [Full Text] [Related]  

  • 24. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 25. [Round table on the "norms for good drug compounding"].
    Boll Chim Farm; 1970 Nov; 109(11):635-52. PubMed ID: 5515584
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 27. WHO expert committee on specifications for pharmaceutical preparations. Twenty-fifth report.
    World Health Organ Tech Rep Ser; 1975; (567):1-115. PubMed ID: 807046
    [No Abstract]   [Full Text] [Related]  

  • 28. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 30. APhA house of delegates endorses policies on pharmaceutical care, therapeutic outcomes, compounding, packaging.
    Am J Hosp Pharm; 1992 Jun; 49(6):1318. PubMed ID: 1529970
    [No Abstract]   [Full Text] [Related]  

  • 31. Sterile Product Packaging and Delivery Systems.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Suggestions and recommendations for a "good production" of drugs].
    Bellentani L; Buonumori E; Castagnola V; Colombo A
    Boll Chim Farm; 1969 Jul; 108(7):403-20. PubMed ID: 5357736
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quality control in the pharmacy].
    Cohen EH
    Pharm Weekbl; 1968 Apr; 103(17):472-85. PubMed ID: 5665059
    [No Abstract]   [Full Text] [Related]  

  • 34. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 37. Basics of sterile compounding: aseptic processing.
    Akers MJ
    Int J Pharm Compd; 2015; 19(1):49-56. PubMed ID: 25902628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compounding and repackaging--a need for complete records.
    Proksch RA
    Hosp Pharm; 1980 Jul; 15(7):344-5, 349-50, 352-5. PubMed ID: 10247655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cleaner medicaments.
    Br Med J; 1973 Apr; 2(5857):6. PubMed ID: 4695717
    [No Abstract]   [Full Text] [Related]  

  • 40. [Elaboration of examination rules for initial substances and end products].
    Hubmann E
    Pharm Acta Helv; 1973; 48(8):443-54. PubMed ID: 4766786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.